The following table provides an overview of the latest patents of The Board Of Trustees Of The Leland Stanford Junior University that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3341015Dec 27, 2023Enhanced Depletion Of Targeted Cells With Cd47 Blockade And An Immune Costimulatory Agonist1
EP3147295Nov 22, 2023New Avv Capsid Proteins For Nucleic Acid Transfer1
EP3795696Apr 26, 2023Identification And Use Of Circulating Nucleic Acid Tumor Markers2
EP3294865Apr 12, 2023Methods Of Producing Epimerases And Benzylisoquinoline Alkaloids1
EP3186395Mar 29, 2023Engraftment Of Stem Cells With A Combination Of An Agent That Targets Stem Cells And Modulation Of Immunoregulatory Signaling1
EP2477648Jul 20, 2022Synergistic Anti-Cd47 Therapy For Hematologic Cancers1
EP2129409Nov 24, 2021Devices And Methods For Application Of Reduced Pressure Therapy1
EP3656443Sep 29, 2021Use Of Trl Agonist And Anti-Cd47 Agent To Enhance Phagocytosis Of Cancer Cells2
EP2827150Aug 18, 2021Imaging And Evaluating Embryos, Oocytes, And Stem Cells1
EP3255061Jun 16, 2021Selective Immunodepletion Of Endogenous Stem Cell Niche For Engraftment1